Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
PHPIX vs BIPIX
Shared holdings
2
PHPIX covered by BIPIX
27.23%
BIPIX covered by PHPIX
27.23%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
PHPIX (April 30, 2026)
| Security | Weight | |
|---|---|---|
| US ULTRA BOND CBT Sep25 | 26.33% | |
| ORGANON & CO | 2.71% | |
| CORCEPT THERAPEUTICS INC | 1.80% | |
| ENLIVEN THERAPEUTICS INC | 1.76% | |
| AXSOME THERAPEUTICS INC | 1.70% | |
| OMEROS CORP | 1.60% | |
| PERRIGO CO PLC | 1.58% | |
| DEFINIUM THERAPEUTICS INC | 1.54% | |
| NEKTAR THERAPEUTICS | 1.51% | |
| TREVI THERAPEUTICS INC | 1.51% | |
| TERNS PHARMACEUTICALS INC | 1.48% | |
| INDIVIOR PHARMACEUTICALS INC | 1.46% | |
| PACIRA BIOSCIENCES INC | 1.46% | |
| HARROW INC | 1.43% | |
| JAZZ PHARMACEUTI | 1.43% | |
| HARMONY BIOSCIENCES HOLDINGS INC | 1.42% | |
| ROYALTY PHARMA-A | 1.40% | |
| AMYLYX PHARMACEUTICALS INC | 1.40% | |
| VIATRIS INC | 1.40% | |
| CRINETICS PHARMACEUTICALS INC | 1.37% | |
| ANI PHARMACEUTICALS INC | 1.36% | |
| LIGAND PHARMACEUTICALS | 1.36% | |
| MBX BIOSCIENCES INC | 1.34% | |
| INNOVIVA INC | 1.34% | |
| LIQUIDIA TECHNOLOGIES INC | 1.33% | |
| AMNEAL PHARM INC | 1.32% | |
| XERIS BIOPHARMA HOLDINGS INC | 1.32% | |
| BRISTOL-MYERS SQUIBB CO | 1.32% | |
| EDGEWISE THERAPEUTICS INC | 1.31% | |
| OCULAR THERAPEUTIX INC | 1.29% | |
| PFIZER INC | 1.28% | |
| NUVATION BIO INC | 1.27% | |
| ZOETIS INC CL A | 1.26% | |
| ELANCO ANIMAL HEALTH INC | 1.25% | |
| JOHNSON&JOHNSON | 1.24% | |
| COLLEGIUM PHARMACEUTICAL INC | 1.24% | |
| MERCK & CO | 1.23% | |
| ALUMIS INC | 1.23% | |
| LILLY ELI and CO | 1.21% | |
| TARSUS PHARMACEUTICALS INC | 1.19% | |
| SUPERNUS PHARMACEUTICALS INC | 1.18% | |
| PHIBRO ANIMAL HEALTH CORP CL A | 1.17% | |
| EYEPOINT PHARMACEUTICALS INC | 1.16% | |
| PRESTIGE CONSUMER HEALTHCARE INC | 1.14% | |
| AMPHASTAR PHARMACEUTICALS INC | 1.11% | |
| THERAVANCE B | 1.00% | |
| PHATHOM PHARMACEUTICALS INC | 0.99% | |
| RAPPORT THERAPEUTICS INC | 0.99% | |
| ESPERION THERAPEUTICS INC NEW | 0.97% | |
| CORMEDIX INC | 0.93% |
BIPIX (April 30, 2026)
| Security | Weight | |
|---|---|---|
| US ULTRA BOND CBT Sep25 | 28.66% | |
| Invesco Government & Agency Portfolio, Institutional Class | 1.97% | |
| APELLIS PHARMACEUTICALS INC | 1.29% | |
| REVOLUTION MEDICINES INC | 1.14% | |
| TRAVERE THERAPEUTICS INC | 1.12% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.00% | |
| TWIST BIOSCIENCE CORP | 0.99% | |
| SUMMIT THERAPEUTICS INC | 0.97% | |
| ALKERMES PLC | 0.96% | |
| TG THERAPEUTICS INC | 0.95% | |
| MADRIGAL PHARMACEUTICALS INC | 0.95% | |
| BEAM THERAPEUTICS INC | 0.92% | |
| APOGEE THERAPEUTICS INC | 0.88% | |
| SCHOLAR ROCK HOLDING CORP | 0.85% | |
| PRAXIS PRECISION MEDICINES INC | 0.85% | |
| EXELIXIS INC | 0.84% | |
| MIRUM PHARMACEUTICALS INC | 0.84% | |
| UNITED THERAPEUTICS CORP DEL | 0.83% | |
| NATERA INC | 0.83% | |
| CRISPR Therapeutics A.G. Series A | 0.83% | |
| CELCUITY INC | 0.83% | |
| KRYSTAL BIOTECH INC | 0.81% | |
| PROTAGONIST THERAPEUTICS INC | 0.81% | |
| NEUROCRINE BIOSCIENCES INC | 0.80% | |
| INCYTE CORP | 0.79% | |
| CG ONCOLOGY INC | 0.79% | |
| CYTOKINETICS INC | 0.79% | |
| NUVALENT INC-A | 0.79% | |
| IONIS PHARMACEUTICALS INC | 0.79% | |
| BRIDGEBIO PHARMA INC | 0.79% | |
| VAXCYTE INC | 0.79% | |
| KYMERA THERAPEUTICS INC | 0.79% | |
| BIOGEN INC | 0.78% | |
| COGENT BIOSCIENCES INC | 0.78% | |
| PTC THERAPEUTICS INC | 0.78% | |
| INSMED INC | 0.77% | |
| ALNYLAM PHARMACEUTICALS INC | 0.76% | |
| ROIVANT SCIENCES | 0.76% | |
| HALOZYME THERAPEUTICS INC | 0.76% | |
| ARCUTIS BIOTHERAPEUTICS INC | 0.74% | |
| SPYRE THERAPEUTICS INC | 0.74% | |
| SOLENO THERAPEUTICS INC | 0.74% | |
| ABBVIE INC | 0.73% | |
| AMGEN INC | 0.72% | |
| REGENERON PHARMACEUTICALS INC | 0.72% | |
| ULTRAGENYX PHARMA INC | 0.72% | |
| ACADIA PHARMACEUTICALS INC | 0.71% | |
| RHYTHM PHARMACEUTICALS INC | 0.71% | |
| GILEAD SCIENCES INC | 0.71% | |
| BIOMARIN PHARMACEUTICAL INC | 0.71% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.